0.48
-1.1077(-69.67%)
Currency In USD
| Previous Close | 1.59 |
| Open | 0.64 |
| Day High | 0.7 |
| Day Low | 0.43 |
| 52-Week High | 29 |
| 52-Week Low | 0.34 |
| Volume | 66.68M |
| Average Volume | 5.44M |
| Market Cap | 1.59M |
| PE | 0.01 |
| EPS | 77.26 |
| Moving Average 50 Days | 1.87 |
| Moving Average 200 Days | 6.3 |
| Change | -1.11 |
If you invested $1000 in ReShape Lifesciences Inc. (RSLS) since IPO date, it would be worth $0 as of April 02, 2025 at a share price of $1.59. Whereas If you bought $1000 worth of ReShape Lifesciences Inc. (RSLS) shares 5 years ago, it would be worth $0.28 as of April 02, 2025 at a share price of $1.59.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
GlobeNewswire Inc.
Mar 10, 2025 12:31 PM GMT
Vagal Neuromodulation Provides Route to Treat Type 2 Diabetes and HypoglycemiaIRVINE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, tod
ReShape Lifesciences® Signs Distribution Agreement in Canada With Liaison Medical for its Next-Generation Lap-Band® 2.0 FLEX
GlobeNewswire Inc.
Feb 25, 2025 1:31 PM GMT
Liaison Medical is Among the Largest Surgical Device Distributors in CanadaIRVINE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today a
ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering
GlobeNewswire Inc.
Feb 16, 2025 4:17 AM GMT
IRVINE, Calif., Feb. 15, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (“ReShape” or the “Company”) (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the pricing of its public offering of